Elevance Health (ELV) Receivables (2009 - 2026)

Elevance Health (ELV) has reported Receivables for 18 consecutive years, with $17.8 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Receivables rose 0.78% year-over-year to $17.8 billion in Q2 2026; TTM through Jun 2026 was $17.8 billion, a 0.78% increase from a year earlier, with the FY2025 full-year figure at $16.4 billion, up 16.77% from the prior year.
• Receivables was $17.8 billion for Q2 2026 at Elevance Health, up from $17.7 billion in the prior quarter.
• Over five years, Receivables peaked at $17.8 billion in Q2 2026 and troughed at $10.3 billion in Q3 2022.
• A 5-year average of $14.1 billion and a median of $13.6 billion in 2023 frame the typical range for Receivables.
• Across the five-year window, Receivables gained 0.67% in 2024 and climbed 29.88% in 2025, its largest moves.
• Over 5 years, Receivables stood at $11.4 billion in 2022, then gained by 16.92% to $13.3 billion in 2023, then increased by 5.41% to $14.0 billion in 2024, then climbed by 16.77% to $16.4 billion in 2025, then advanced by 8.72% to $17.8 billion in 2026.
• The last three Receivables figures came in at $17.8 billion (Q2 2026), $17.7 billion (Q1 2026), and $16.4 billion (Q4 2025), per Business Quant data.